Financial results - THERAPY ANGYPLANT S.R.L.

Financial Summary - Therapy Angyplant S.r.l.
Unique identification code: 43470995
Registration number: J22/3172/2020
Nace: 4775
Sales - Ron
72.080
Net Profit - Ron
1.895
Employees
2
Open Account
Company Therapy Angyplant S.r.l. with Fiscal Code 43470995 recorded a turnover of 2024 of 72.080, with a net profit of 1.895 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor cosmetice şi de parfumerie having the NACE code 4775.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Therapy Angyplant S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 0 71.526 63.361 66.471 72.080
Total Income - EUR - - - - - 0 71.526 66.496 66.471 77.739
Total Expenses - EUR - - - - - 0 69.759 64.458 64.708 74.802
Gross Profit/Loss - EUR - - - - - 0 1.767 2.037 1.763 2.937
Net Profit/Loss - EUR - - - - - 0 1.121 1.467 1.190 1.895
Employees - - - - - 0 1 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 9.0%, from 66.471 euro in the year 2023, to 72.080 euro in 2024. The Net Profit increased by 712 euro, from 1.190 euro in 2023, to 1.895 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Therapy Angyplant S.r.l.

Rating financiar

Financial Rating -
THERAPY ANGYPLANT S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Therapy Angyplant S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Therapy Angyplant S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Therapy Angyplant S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Therapy Angyplant S.r.l. - CUI 43470995

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 343 223 879 470 1.061
Current Assets - - - - - 18.200 19.505 18.006 18.624 14.407
Inventories - - - - - 17.468 17.882 15.050 16.611 14.098
Receivables - - - - - 0 0 1.201 4 0
Cash - - - - - 732 1.623 1.754 2.009 309
Shareholders Funds - - - - - 41 1.162 2.632 3.814 5.688
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 18.501 18.566 16.253 15.280 9.780
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4775 - 4775"
CAEN Financial Year 4775
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.407 euro in 2024 which includes Inventories of 14.098 euro, Receivables of 0 euro and cash availability of 309 euro.
The company's Equity was valued at 5.688 euro, while total Liabilities amounted to 9.780 euro. Equity increased by 1.895 euro, from 3.814 euro in 2023, to 5.688 in 2024.

Risk Reports Prices

Reviews - Therapy Angyplant S.r.l.

Comments - Therapy Angyplant S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.